StayCurrentMD · Safety and utility of long-acting steroid injection for management of post-operative stricture in patients with anorectal malformation and hirschsprung disease
Article1 min read·Published Aug 2025

Safety and utility of long-acting steroid injection for management of post-operative stricture in patients with anorectal malformation and hirschsprung disease

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Aug 2025 · 1 min read

In brief

In brief

This study evaluates triamcinolone acetonide injection as a treatment for anastomotic strictures following surgical repair of anorectal malformations and Hirschsprung disease. The long-acting steroid approach aims to reduce stricture recurrence and minimize repeat interventions in pediatric colorectal patients.

  • Anastomotic stricture is a major source of post-operative morbidity in ARM and Hirschsprung disease patients.
  • Triamcinolone acetonide (TAC) injection after dilation reduces stricture recurrence in other conditions.
  • TAC's safety and efficacy for post-operative stricture management in ARM/HSCR remains unstudied.
  • Long-acting steroid injection may decrease the number of interventions needed to resolve strictures.
  • This represents a potential therapeutic gap in pediatric colorectal surgery post-operative care.

Written by the GCMD Library team from the article.

Anastomotic stricture leads to significant post-operative morbidity for patients with anorectal malformations (ARM) and Hirschsprung Disease (HSCR). The injection of the long-acting steroid triamcinolone acetonide (TAC) after stricture dilation has been shown to decrease stricture recurrence and interventions needed to achieve resolution but has yet to be studied in patients with ARM or HSCR.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →